ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

ClinicalTrials.gov ID: NCT01203358

Public ClinicalTrials.gov record NCT01203358. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 8:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Exosurf Neonatal and Survanta for the Treatment of Respiratory Distress Syndrome

Study identification

NCT ID
NCT01203358
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
NICHD Neonatal Research Network
Network
Enrollment
617 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Up to 6 Hours
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 1990
Primary completion
Dec 31, 1991
Completion
Dec 31, 1991
Last update posted
Mar 21, 2019

1991 – 1992

United States locations

U.S. sites
13
U.S. states
12
U.S. cities
13
Facility City State ZIP Site status
Stanford University Palo Alto California 94304
Yale University New Haven Connecticut 06504
George Washington University Washington D.C. District of Columbia 20052
University of Miami Miami Florida 33136
Emory University Atlanta Georgia 30303
Indiana University Indianapolis Indiana 46202
Wayne State University Detroit Michigan 48201
University of New Mexico Albuquerque New Mexico 87131
Cincinnati Children's Medical Center Cincinnati Ohio 45267
Case Western Reserve University, Rainbow Babies and Children's Hospital Cleveland Ohio 44106
University of Tennessee Memphis Tennessee 38163
University of Texas Southwestern Medical Center at Dallas Dallas Texas 75235
University of Vermont Burlington Vermont 05405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01203358, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 21, 2019 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01203358 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →